NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

I was the CEO of a subsidiary of a publicly traded company. You might have a better insight into regulated corporate governance than I do, but unless you have a significant event to discuss that requires explanation to investors, you don't do CC's. Obtaining financing, acquisition of production facilities and DL are stepping stones that are self explanatory and requires no additional explanation. CC's are events that smaller companies with no significant corporate governance lawyers and management on staff should avoid. This is just my opinion as a former corporate lawyer and CEO. The less 'touch' management have with investors, the less likelihood there will be miscommunications and shareholder liability.